Back to top
more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

96.59
692,880

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

PerkinElmer (PKI) Q3 Earnings Surpass Estimates

by Zacks Equity Research

PerkinElmer (PKI) delivered earnings and revenue surprises of 2.03% and 30.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer (PKI) to Post Q3 Earnings: What's in the Cards?

by Zacks Equity Research

PerkinElmer's (PKI) third-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for discovery business and informatics franchise.

Bruker (BRKR) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Bruker (BRKR) delivered earnings and revenue surprises of 24.53% and 4.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer (PKI) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

by Zacks Equity Research

PerkinElmer (PKI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will PerkinElmer (PKI) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Industry Outlook Highlights Mettler-Toledo, PerkinElmer and Waters

by Zacks Equity Research

Mettler-Toledo, PerkinElmer and Waters have been highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

3 Stocks to Watch on Rising Demand for Scientific Instruments

by Aniruddha Ganguly

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), Waters (WAT) and PerkinElmer (PKI) are gaining from strong life science, pharmaceutical and academic end-market demand, as well as rising healthcare spending.

BD's (BDX) New Cloud Software Solution to Boost Lab Workflow

by Zacks Equity Research

BD's (BDX) latest launch is expected to provide scientists with an integrated ecosystem that enables optimization of panel design, collaboration and analysis.

    PerkinElmer's (PKI) New Benchtop Platform to Boost Workflows

    by Zacks Equity Research

    PerkinElmer's (PKI) latest launch is expected to enable researchers to multiplex and perform immunophenotyping and viability assays in a lesser time with a simplified user interface.

    PerkinElmer's (PKI) Reagent Kit Receives FDA Clearance

    by Zacks Equity Research

    PerkinElmer's (PKI) T-Cell Select reagent kit is expected to allow for a more automated workflow following the FDA's approval.

    Here's Why You Should Retain PerkinElmer (PKI) Stock Now

    by Zacks Equity Research

    PerkinElmer (PKI) continues to gain from solid product portfolio despite forex woes.

    Indrajit Bandyopadhyay headshot

    U.S. Market Faces Worst Meltdown Since 2020: Here's Why

    by Indrajit Bandyopadhyay

    Major U.S. indices nosedived on Sep 14 following the inflation report for the month of August.

    PerkinElmer (PKI) Down 11.6% Since Last Earnings Report: Can It Rebound?

    by Zacks Equity Research

    PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Here's Why You Should Retain PerkinElmer (PKI) Stock Now

    by Zacks Equity Research

    PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

    Company News for Aug 2, 2022

    by Zacks Equity Research

    Companies in The News Are: BA, XOM, HSBC, PKI

    PerkinElmer (PKI) Q2 Earnings and Revenues Surpass Estimates

    by Zacks Equity Research

    PerkinElmer's (PKI) second-quarter results benefit from a solid performance at Discover & Analytics Solutions business.

    PerkinElmer (PKI) Q2 Earnings and Revenues Top Estimates

    by Zacks Equity Research

    PerkinElmer (PKI) delivered earnings and revenue surprises of 14.29% and 2.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

    Earnings Preview: PerkinElmer (PKI) Q2 Earnings Expected to Decline

    by Zacks Equity Research

    PerkinElmer (PKI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Indrajit Bandyopadhyay headshot

    3 Gene Sequencing Stocks With Potential to Gain in 2H22

    by Indrajit Bandyopadhyay

    Here we look at three stocks, PKI, TMO and TXG, with robust genome sequencing capabilities that investors can keep a watch on.

    Here's Why You Should Retain PerkinElmer (PKI) Stock Now

    by Zacks Equity Research

    PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

    PerkinElmer (PKI) Unveils GC Platform to Simplify Lab Operations

    by Zacks Equity Research

    PerkinElmer's (PKI) newly introduced next-generation, automated GC platform can help simplify lab operations and offer excellent precision for high throughput environments.

    PerkinElmer's (PKI) Arm Introduces Two CE-Marked Assays

    by Zacks Equity Research

    PerkinElmer's (PKI) company launches two CE-marked antibody tests that can support the analysis of the immune response to COVID-19.

    PerkinElmer's (PKI) Latest Launch to Expand Food Safety Suite

    by Zacks Equity Research

    PerkinElmer's (PKI) microbial plates minimize human error by providing standardized protocols and offer a small footprint to save space in incubators and storage areas.

    PerkinElmer (PKI) Unveils New NGS System to Aid Genomic Analysis

    by Zacks Equity Research

    PerkinElmer's (PKI) introduction of the RUO BioQule NGS System is a cost-effective system that can bring improvements in genomic analysis.

    Why Is Bruker (BRKR) Up 6.3% Since Last Earnings Report?

    by Zacks Equity Research

    Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.